Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Abediterol in Asthma
NCT03273127Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in asthma comparing Abediterol 5 μg with Placebo (2 arms). Primary endpoints: Maximum Plasma Concentration at Day 9, Time to Maximum Plasma Concentration at Day 9 and 13 more. Started Sep 2017; status: completed.
02
Drugs
abediterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03273127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273127.